ALPHARETTA, Ga., Oct. 25,
2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:
AVNS) will webcast its conference call discussing financial results
and business highlights for the third quarter 2023
on Wednesday, Nov. 1 at 9 a.m.,
ET. The company will issue a news release detailing its
results before the market opens that same day.
The conference call will be hosted by Joe Woody, chief executive officer, and
Michael Greiner, senior vice
president, chief financial officer, and chief transformation
officer.
To join the live conference call, dial 877-240-5772 in the
United States. A simultaneous
webcast of the call and a related presentation will be accessible
via the Investors section of the Avanos Medical
website, https://avanos.investorroom.com/.
A replay of the conference call will be available Nov. 1
at noon ET by dialing 877-344-7529 in the United
States and entering passcode 9384291. It will be available for
one week. A replay of the webcast also will be accessible in
the Investors section of the website, approximately one
hour following the completion of the conference call.
About Avanos Medical
Avanos Medical (NYSE: AVNS) is a
medical technology company focused on delivering clinically
superior medical device solutions that will help patients get back
to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to
addressing some of today's most important healthcare needs,
including providing a vital lifeline for nutrition to patients from
hospital to home, and reducing the use of opioids while helping
patients move from surgery to recovery. Avanos develops,
manufactures, and markets its recognized brands globally and holds
leading market positions in multiple product categories. For more
information, visit www.avanos.com and follow Avanos
Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-webcast-conference-call-discussing-third-quarter-2023-financial-results-301967371.html
SOURCE Avanos Medical, Inc.